Latest liver disease Stories
- Nonalcoholic Steatohepatitis is a progressive liver disease associated with increased risk for liver cirrhosis, hepatocellular cancer, metabolic and cardiovascular disease - MODI'IN,
SAINT PREX, Switzerland and AMSTERDAM, April 22, 2015 /PRNewswire/ -- Elsevier, the journal Digestive and Liver Disease and Ferring Pharmaceuticals announce
RnRMarketResearch.com adds “Fatty Liver Disease – Pipeline Review, H1 2015” to its store.
LEXINGTON, Massachusetts, April 9, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the 13-week Phase 2 IMAGO trial of its investigational compound
LOS ANGELES, April 8, 2015 /PRNewswire/-- Endonovo Therapeutics, Inc.
FDA approves oral therapy as a first-in-class treatment BALTIMORE, March 17, 2015 /PRNewswire-USNewswire/ -- Asklepion Pharmaceuticals, LLC. today announced that the U.S.
TEL AVIV, Israel, March 17, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
MILFORD, Mass., March 12, 2015 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of hepatitis B and
LONDON, March 9, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides
TEL AVIV, Israel, March 2, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
- A hairdresser.